MRPL22
Large ribosomal subunit protein uL22m
Also known as: HSPC158, MRP-L25, RM22_HUMAN, RPML25
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NWU5
- Gene
- MRPL22
- Ensembl
- ENSG00000082515
- Chromosome
- 5
- Canonical length
- 206 aa
- Protein class
- Predicted intracellular proteins, Ribosomal proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein that belongs to the L22 ribosomal protein family. A pseudogene corresponding to this gene is found on chromosome 4q. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
206 residues, UniProt reviewed canonical sequence.
>Q9NWU5|MRPL22
1 MAAAVLGQLG ALWIHNLRSR GKLALGVLPQ SYIHTSASLD ISRKWEKKNK IVYPPQLPGE
61 PRRPAEIYHC RRQIKYSKDK MWYLAKLIRG MSIDQALAQL EFNDKKGAKI IKEVLLEAQD
121 MAVRDHNVEF RSNLYIAEST SGRGQCLKRI RYHGRGRFGI MEKVYCHYFV KLVEGPPPPP
181 EPPKTAVAHA KEYIQQLRSR TIVHTLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MRPL22 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 46 nTPM
Expression across tissuesHPA
Tissue
- liver: 46 nTPM
- heart muscle: 44 nTPM
- bone marrow: 39 nTPM
- kidney: 38 nTPM
- skeletal muscle: 37 nTPM
- adrenal gland: 37 nTPM
Single-cell type
- late primary spermatocytes: 267 nCPM
- oocytes: 240 nCPM
- gastric progenitor cells: 203 nCPM
- esophageal basal cells: 188 nCPM
- esophageal suprabasal cells: 176 nCPM
- cytotrophoblasts: 172 nCPM
Immune cell
- T-reg: 75 nTPM
- memory B-cell: 73 nTPM
- myeloid DC: 67 nTPM
- NK-cell: 64 nTPM
- total PBMC: 62 nTPM
- naive B-cell: 62 nTPM
Brain region
- cerebellum: 14 nTPM
- pons: 14 nTPM
- medulla oblongata: 14 nTPM
- cerebral cortex: 14 nTPM
- white matter: 13 nTPM
- hypothalamus: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.2
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.27
- DepMap mean gene effect
- -0.33
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Large ribosomal subunit protein uL22
- Ribosomal protein uL22 superfamily
- Ribosomal protein L22p/L17e
- Large ribosomal subunit protein uL22, bacteria/organella
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MRPL22 as an antibody target. Whether an autoantibody or antibody against MRPL22 could matter depends on whether native MRPL22 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MRPL22 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MRPL22 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...